US Patent Issued to MEDSHINE DISCOVERY on March 25 for "Glucoside derivative that acts as SGLT1 inhibitor and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,367, issued on March 25, was assigned to MEDSHINE DISCOVERY INC. (Nanjing, China).

"Glucoside derivative that acts as SGLT1 inhibitor and application thereof" was invented by Yi Li (Shanghai), Tao Yu (Shanghai), Qinghua Mao (Shanghai), Chengde Wu (Shanghai) and Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A glucoside derivative that acts as an SGLT1 inhibitor and an application thereof in the preparation of a drug for SGLT1 related diseases. Specifically disclosed is a compound represented by formula (II), a tautomer thereof or a pharmaceutically acceptable composition thereof."

The patent was filed on March 30, 2020, under...